Ruxolitinib treatment ameliorates clinical, immunologic, and transcriptomic aberrations in patients with STAT3 gain-of-function disease.

Bayram Catak F., Catak M. C., Babayeva R., Toubia J., Warnock N. I., Celmeli F., ...Daha Fazla

The Journal of allergy and clinical immunology, cilt.155, sa.3, ss.784-791, 2025 (SCI-Expanded, Scopus)

• Yayın Türü: Makale / Tam Makale
• Cilt numarası: 155 Sayı: 3
• Basım Tarihi: 2025
• Doi Numarası: 10.1016/j.jaci.2024.11.032
• Dergi Adı: The Journal of allergy and clinical immunology
• Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, PASCAL, BIOSIS, CAB Abstracts, Food Science & Technology Abstracts, International Pharmaceutical Abstracts, MEDLINE, Veterinary Science Database, Nature Index
• Sayfa Sayıları: ss.784-791
• Anahtar Kelimeler: immune dysregulation, immunologic assessment, ruxolitinib, STAT3 GOF, transcriptomic profiling
• Hacettepe Üniversitesi Adresli: Evet